Wuhan Hhd Supply Pharmaceutical Chemicals Tofacitinib Citrate 540737-29-9 for Rheumatoid Arthritis

• Powder: Yes
• Customized: Non-Customized
• Suitable for: Adult
• Purity: >98%
• Color: White
• Grade: Pharmaceutical Grade
• Transport Package: Alumininum Foli Bags
• Specification: 10g, 50g, 200g, 1kg, 5kg
• Trademark: hhdpharm
• Origin: China

Product Description

Wuhan HHD Supply Pharmaceutical Chemicals Tofacitinib Citrate 540737-29-9 for Rheumatoid Arthritis

 

Basic information:

Product Name	Tofacitinib citrate
CAS	540737-29-9
MF	C16H20N6O.C6H8O7
MW	504.497
EINCES	638-826-4
Assay	99%
Brand Name	Golt Biotech
Appearance	white powder
Storage	Preserve in tight,light-resistant containers in a cool place
Shelf life	2 years when properly stored.

 

Usage:

(1).Tofacitinib citrate is a king of drugs developed by the US pharmaceutical company for treating rheumatoid arthritis, for the treatment of methotrexate inadequate response or intolerance to severe active rheumatoid arthritis (RA) in adult patients. Tofacitinib citrate is approved for the treatment of methotrexate inadequate response or intolerance to severe active rheumatoid joints arthritis (RA) in adult patients.

(2). It can be used as monotherapy or in combination with methotrexate or other non-biological disease-modifying antirheumatic drugs (the DMARD) in combination. This medicine should not be in combination with biological DMARD or strong immunosuppressants (such as cyclosporine and azathioprine) . Tofacitinib citrate is approved by the daily dose of 2 times, each time 5mg. Seven clinical trials evaluated the safety and efficacy of Tofacitinib citrate in moderate to severe active RA in adult patients. In all tests, compared with patients receiving placebo, patients receiving Tofacitinib citrate treatment showed significant improvement in clinical response and physical function.abbreviated as NAD+ and NADH respectively.